CRP and COVID-19: We aim to investigate the diagnostic accuracy and prognostic utility of the above-described inflammatory biomarkers (IL-6, CRP, PCT, ferritin, and leukocytes) to predict hospitalisation and outcome in cases with COVID-19 and compare them with cases with respiratory infections other than COVID-19.